Browse by Title

Type here to filter the list

I
Iatrogenic Aortocoronary Dissection of the Right Coronary Artery During Routine Diagnostic Angiography Using a Tiger Catheter

Ronald Santos, MD – Dr. HB Calleja Heart and Vascular Institute, St. Luke's Medical Center - Quezon City ### 1871957###Speaker###Interventional Cardiology Research Fellow###Dr. HB Calleja Heart and Vascular Institute, St. Luke's Medical Center - Quezon City###
Speaker: Ronald Santos, MD – Dr. HB Calleja Heart and Vascular Institute, St. Luke's Medical Center - Quezon City
###
Iatrogenic Case of Catheter Induced Multivessel Coronary Artery Dissection Treated with Urgent Imaging Guided Multivessel PCI

Sujay R. Kamisetty, MD (he/him/his) – University of Florida ### 1871950###Speaker###Resident Physician###University of Florida###
Speaker: Sujay R. Kamisetty, MD (he/him/his) – University of Florida
### he/him/his
ICE Only for LAA Closure

Creighton W. Don, MD – University of Washington ### 272757###Speaker###Professor of Medicine/Cardiology Director of the Interventional Cardiology and Structural Heart Fellowships###University of Washington###
Speaker: Creighton W. Don, MD – University of Washington
###
ICE only LAA Closure

Creighton W. Don, MD – University of Washington ### 272757###Speaker###Professor of Medicine/Cardiology Director of the Interventional Cardiology and Structural Heart Fellowships###University of Washington###
Speaker: Creighton W. Don, MD – University of Washington
###
If Only I had Prepared the Lesion Better! Case-Based Discussion

Richard A. Anderson, MD – Cardiff and Vale University Health Board ### 608527###Speaker###Consultant Interventional Cardiologist###Cardiff and Vale University Health Board###
Speaker: Richard A. Anderson, MD – Cardiff and Vale University Health Board
###
Imaging Considerations for Prevention of Coronary Obstruction

Jaffar M. Khan, MD, PhD, FSCAI – St Francis Hospital and Heart Center ### 320262###Speaker###Interventional Cardiologist###St Francis Hospital and Heart Center###
Speaker: Jaffar M. Khan, MD, PhD, FSCAI – St Francis Hospital and Heart Center
###
Imaging Fundamentals for Transcatheter Tricuspid Valve Intervention Understanding the Normal and Abnormal Tricuspid Valve

Rebecca T. Hahn, MD – Columbia University/NewYork-Presbyterian Hospital ### 163128###Speaker###Director of Interventional Echocardiography###Columbia University/NewYork-Presbyterian Hospital###
Speaker: Rebecca T. Hahn, MD – Columbia University/NewYork-Presbyterian Hospital
###
Imaging Guidance During Complex and High-Risk PCI

Robert Diletti, MD ### 467902###Speaker#########
Speaker: Robert Diletti, MD
###
Imaging Guided PCI: Today’s Evidence and Ongoing Studies

Ziad Ali, MD, DPhil – DeMatteis Cardiovascular Institute ### 263772###Speaker###Director###DeMatteis Cardiovascular Institute###
Speaker: Ziad Ali, MD, DPhil – DeMatteis Cardiovascular Institute
###
Imaging Screening for Transcatheter Mitral Intervention

Edwin C. Ho, MD (he/him/his) – Montefiore Medical Center ### 1806694###Speaker###Director, Structural Heart Imaging; Co-director, Structural Heart Center###Montefiore Medical Center###
Speaker: Edwin C. Ho, MD (he/him/his) – Montefiore Medical Center
### he/him/his
IMAGING THE AORTIC VALVE

Jaffar M. Khan, MD, PhD, FSCAI – St Francis Hospital and Heart Center ### 320262###Moderator###Interventional Cardiologist###St Francis Hospital and Heart Center###
Moderator: Jaffar M. Khan, MD, PhD, FSCAI – St Francis Hospital and Heart Center
### @@@ Jonathon Leipsic, MD, FRCPC – St. Paul's Hospital ### 163186###Moderator###Professor of Radiology and Cardiology###St. Paul's Hospital###
Moderator: Jonathon Leipsic, MD, FRCPC – St. Paul's Hospital
### @@@ Gaby Weissman, MD – MedStar Washington Hospital Center & Medstar Georgetown University Hospital ### 163339###Moderator###Chief Clinical Cardiology###MedStar Washington Hospital Center & Medstar Georgetown University Hospital ###
Moderator: Gaby Weissman, MD – MedStar Washington Hospital Center & Medstar Georgetown University Hospital
###
IMAGING THE LAA

Preetham Kumar, MD – MedStar Heart and Vascular Institute ### 671180###Moderator###Director, Echocardiography laboratory###MedStar Heart and Vascular Institute###
Moderator: Preetham Kumar, MD – MedStar Heart and Vascular Institute
### @@@ Brijeshwar S. Maini, MD – East End Medical ### 163205###Moderator###Executice Chairman###East End Medical###
Moderator: Brijeshwar S. Maini, MD – East End Medical
### @@@ Jonathan G. Schwartz, MD (he/him/his) – Sanger Heart & Vascular Institute/Atrium Health ### 1546638###Moderator###Medical Director, Interventional Cardiology###Sanger Heart & Vascular Institute/Atrium Health###
Moderator: Jonathan G. Schwartz, MD (he/him/his) – Sanger Heart & Vascular Institute/Atrium Health
### he/him/his
IMAGING THE MITRAL & TRICUSPID VALVE

Federico M. Asch, MD – MedStar Health Research Institute ### 163009###Moderator###Director, Cardiovascular Core Labs and Cardiac Imaging Research###MedStar Health Research Institute###
Moderator: Federico M. Asch, MD – MedStar Health Research Institute
### @@@ Rebecca T. Hahn, MD – Columbia University/NewYork-Presbyterian Hospital ### 163128###Moderator###Director of Interventional Echocardiography###Columbia University/NewYork-Presbyterian Hospital###
Moderator: Rebecca T. Hahn, MD – Columbia University/NewYork-Presbyterian Hospital
###
Impact of a CMD Diagnosis

Odayme Quesada, MD, MHS, FACC, FAHA, FESC (she/her/hers) – The Christ Hospital ### 1880527###Speaker###Medical Director, Women’s Heart Center; Ginger Warner Endowed Chair in Women’s Cardiovascular Health; Assistant Professor of Internal Medicine, University of Cincinnati ###The Christ Hospital###
Speaker: Odayme Quesada, MD, MHS, FACC, FAHA, FESC (she/her/hers) – The Christ Hospital
### she/her/hers
Impact Of Calcified Nodules On 2-year Clinical Outcomes After Ivl-assisted Coronary Stenting: Pooled Analysis From The Disrupt Cad Oct Sub-studies

Richard Shlofmitz, MD – St Francis Hospital- The Heart Center ### 202535###Speaker###Chairman of Cardiology###St Francis Hospital- The Heart Center###
Speaker: Richard Shlofmitz, MD – St Francis Hospital- The Heart Center
###
Impact Of Left Ventricular Ejection Fraction On 10-year Mortality After Percutaneous Coronary Intervention Or Coronary Artery Bypass Grafting : Is Cabg Safer Than Pci In All Patients With Reduced Ejection Fraction?

Patrick W. Serruys, MD, PhD – University of Galway, Ireland ### 163289###Speaker###Professor of Medical Intervention & Innovation###University of Galway, Ireland###
Speaker: Patrick W. Serruys, MD, PhD – University of Galway, Ireland
###
Impact of Medication Changes on Blood Pressure Among Black Americans After Renal Denervation: Results from the Spyral HTN-ON MED Trial

Raymond Townsend, MD (he/him/his) – University of Pennsylvania ### 188314###Speaker###Professor###University of Pennsylvania###
Speaker: Raymond Townsend, MD (he/him/his) – University of Pennsylvania
### he/him/his
Impact of Mitral Annular Calcification on Outcomes After Mitral Transcatheter Edge-to-Edge Repair

Taha Hatab, MD – Houston Methodist Hospital ### 1871494###Speaker###Postdoctoral Research Fellow###Houston Methodist Hospital###
Speaker: Taha Hatab, MD – Houston Methodist Hospital
###
Impact of the Transition from MDD to MDR on Medical Device Development

Aaron V. Kaplan, MD, FSCAI, FACC, FNAI – Dartmouth Health Geisel School of Medicine at Dartmouth ### 185995###Speaker###Professor of Medicine###Dartmouth Health Geisel School of Medicine at Dartmouth###
Speaker: Aaron V. Kaplan, MD, FSCAI, FACC, FNAI – Dartmouth Health Geisel School of Medicine at Dartmouth
###
Impact on US Regulatory Analyses and Recommendations

Andrew Farb, MD – U.S. Food and Drug Administration ### 163094###Speaker###Chief Medical Officer, Division of Cardiovascular Devices###U.S. Food and Drug Administration###
Speaker: Andrew Farb, MD – U.S. Food and Drug Administration
###
Impaction of an IMPELLA CP Catheter in Iliac Artery and its Removal Using Snare

Deepak Jain, MD, FACC – Sana Kliniken Lübeck, Germany ### 1871955###Speaker###Director Interventional Cardiology###Sana Kliniken Lübeck, Germany###
Speaker: Deepak Jain, MD, FACC – Sana Kliniken Lübeck, Germany
###
IMPELLA Assisted Multivascular PCI with Left Main Involvement via Aortobifemoral Bypass Graft in a Vasculopath Patie

Abhinav Sood, MD (he/him/his) – Ascension Borgess Hospital ### 1871944###Speaker###Interventional Cardiology fellow###Ascension Borgess Hospital###
Speaker: Abhinav Sood, MD (he/him/his) – Ascension Borgess Hospital
### he/him/his
IMPELLA Assisted Multivessel PCI: Lessons Learned as Early Career Interventionalist

Kameel Kassab, MD (he/him/his) – Yuma Regional Medical Center ### 1546534###Speaker###Interventional Cardiologist###Yuma Regional Medical Center###
Speaker: Kameel Kassab, MD (he/him/his) – Yuma Regional Medical Center
### he/him/his
IMPELLA Utilization in High-Risk Percutaneous Coronary Intervention Mitigates the Risks of Procedural and Clinical Adverse Events Independent of Left Ventricular Ejection Fraction: The Protect III Study

Arsalan Abu-Much, MD – The Cardiovascular Research Foundation-New York ### 1871495###Speaker###Senior Cardiologist ###The Cardiovascular Research Foundation-New York ###
Speaker: Arsalan Abu-Much, MD – The Cardiovascular Research Foundation-New York
###
Impella Versus Non-impella For High-risk Percutaneous Coronary Intervention: An Institutional Cohort Comparison

Pavan Reddy, MD – Medstar Washington Hospital Center ### 1871747###Speaker###Interventional Cardiology Fellow###Medstar Washington Hospital Center ###
Speaker: Pavan Reddy, MD – Medstar Washington Hospital Center
###
IMPELLA-Supported High-Risk PCI in Severe Aortic Stenosis

Katherine Lee Chuy, MD – Loma Linda University Medical Center ### 1859224###Speaker###Interventional Cardiology Fellow###Loma Linda University Medical Center###
Speaker: Katherine Lee Chuy, MD – Loma Linda University Medical Center
###
Implantable Devices for Pulmonary Hypertension

William T. Abraham, MD – The Ohio State University ### 627210###Speaker###Professor of Medicine###The Ohio State University###
Speaker: William T. Abraham, MD – The Ohio State University
###
Implantation Of Contemporary Transcatheter Valves In Patients With Extra-small Annuli Undergoing Tavr - From Tavi-small 2 Registry

Pier Pasquale Leone, MD – Montefiore Medical Center ### 1545028###Speaker###Visiting Cardiology Fellow ###Montefiore Medical Center###
Speaker: Pier Pasquale Leone, MD – Montefiore Medical Center
###
IMPLEMENTING CARDIOGENIC SHOCK INITIATIVES: BUILDING THE SHOCK TEAM

Daniel Burkhoff, MD, PhD – Cardiovascular Research Foundation ### 163047###Moderator###Director: Heart Failure, Hemodynamics and MCS Research###Cardiovascular Research Foundation###
Moderator: Daniel Burkhoff, MD, PhD – Cardiovascular Research Foundation
### @@@ Michael A. Kutcher, MD – Wake Forest University School of Medicine ### 817384###Moderator###Emeritus Professor of Internal Medicine###Wake Forest University School of Medicine###
Moderator: Michael A. Kutcher, MD – Wake Forest University School of Medicine
### @@@ Srihari S. Naidu, MD, FSCAI – Westchester Medical Center ### 163225###Moderator###Director, Cath Labs and HCM Program###Westchester Medical Center###
Moderator: Srihari S. Naidu, MD, FSCAI – Westchester Medical Center
### @@@ Michele D. Voeltz, MD, FACC, FSCAI – Northside Cardiovascular Institute ### 1222247###Moderator###Attending Physician###Northside Cardiovascular Institute###
Moderator: Michele D. Voeltz, MD, FACC, FSCAI – Northside Cardiovascular Institute
###
Inari Fellows Reception - Sponsored by Inari Medical
Incidence, Predictors, Mechanisms, and Evolution of Severe Peri-Device Leaks with Two Different Left Atrial Appendage Occluders: New Insights from AMULET IDE Trial

Dhanunjaya Lakkireddy, MD – Kansas City Heart Rhythm Institute and Research Foundation ### 469428###Speaker###Professor; Electrophysiologist###Kansas City Heart Rhythm Institute and Research Foundation###
Speaker: Dhanunjaya Lakkireddy, MD – Kansas City Heart Rhythm Institute and Research Foundation
###
INCORPORATING REAL WORLD DATA INTO REGULATORY AND CLINICAL DECISION MAKING: CHALLENGES AND OPPORTUNITIES

Mitchell Krucoff, MD, FACC (he/him/his) – Duke University Medical Center/Duke Clinical Research Institute ### 163174###Moderator###Professor Medicine/Cardiology###Duke University Medical Center/Duke Clinical Research Institute###
Moderator: Mitchell Krucoff, MD, FACC (he/him/his) – Duke University Medical Center/Duke Clinical Research Institute
### he/him/his @@@ Bram Zuckerman, MD – U.S. Food and Drug Administration ### 163359###Moderator###Director Office of CV Devices###U.S. Food and Drug Administration###
Moderator: Bram Zuckerman, MD – U.S. Food and Drug Administration
###
Incremental Predictive Value of Cardiac Troponin Positivity and Right Ventricular Strain Added to PESI Risk Class in Submassive Pulmonary Embolism

Ufuk Vardar, MD (he/him/his) – John H. Stroger Hospital of Cook County ### 1871496###Speaker###Resident Physician###John H. Stroger Hospital of Cook County###
Speaker: Ufuk Vardar, MD (he/him/his) – John H. Stroger Hospital of Cook County
### he/him/his
Indications for and Outcomes of Surgical Management of Tricuspid Valve Disease

Steven F. Bolling, MD – University of Michigan Hospital ### 163034###Speaker###Professor of Cardiac Surgery###University of Michigan Hospital###
Speaker: Steven F. Bolling, MD – University of Michigan Hospital
###
Industry Perspective

Charles A. Simonton, MD, FACC, FSCAI – Abiomed Inc ### 163295###Speaker###EVP Chief Medical Officer ###Abiomed Inc###
Speaker: Charles A. Simonton, MD, FACC, FSCAI – Abiomed Inc
###
Industry Perspective

Joie Meikle ### 1886676###Speaker#########
Speaker: Joie Meikle
###
Industry Perspective

Samuel Conaway, MD ### 1916173###Speaker#########
Speaker: Samuel Conaway, MD
###
Industry Perspective on Managing Software and AI Changes

Tarek Haddad, MS ### 328176###Speaker#########
Speaker: Tarek Haddad, MS
###
Industry Perspectives on Tricuspid Valve Interventions in 2023?

Neil E. Moat, MS, FRCS (he/him/his) – Abbott ### 266274###Speaker###Chief Medical Officer/DVP, Structural Heart###Abbott###
Speaker: Neil E. Moat, MS, FRCS (he/him/his) – Abbott
### he/him/his
Industry Roundtable | How Can Registries Help Unburden EU MDR Requirements?
Inequalities in Healthcare Providers in Clinical Trials

Rhian E. Davies, DO MS – WellSpan York Hospital ### 656675###Speaker###Interventional Cardiology ###WellSpan York Hospital###
Speaker: Rhian E. Davies, DO MS – WellSpan York Hospital
###
Infectious Endocarditis: A New Field for Transcatheter Therapy?

Hans R. Figulla, MD, PhD – Universitätsklinikum Jena ### 163099###Speaker###Full Professor emeritus###Universitätsklinikum Jena###
Speaker: Hans R. Figulla, MD, PhD – Universitätsklinikum Jena
###
Informed Consent for Shock Studies Working Group

Navin K. Kapur, MD, FSCAI FAHA FACC – Tufts Medical Center ### 163156###Panel Moderator###Executive Director, CVCRI###Tufts Medical Center###
Panel Moderator: Navin K. Kapur, MD, FSCAI FAHA FACC – Tufts Medical Center
### @@@ John S. Sapirstein, MD – US Food and Drug Administration ### 627214###Panel Moderator###Medical Officer###US Food and Drug Administration###
Panel Moderator: John S. Sapirstein, MD – US Food and Drug Administration
### @@@ Pablo Morales, MD – Division of Cardiovascular Devices / FDA ### 195227###Panel Discussant###Medical Officer###Division of Cardiovascular Devices / FDA###
Panel Discussant: Pablo Morales, MD – Division of Cardiovascular Devices / FDA
### @@@ Graham Nichol, MD, MPH ### 1306590###Panel Discussant#########
Panel Discussant: Graham Nichol, MD, MPH
### @@@ Holger Thiele, MD – Heart Center Leipzig ### 596071###Panel Discussant###Head of department###Heart Center Leipzig###
Panel Discussant: Holger Thiele, MD – Heart Center Leipzig
### @@@ Nick E. West, MA MD FRCP FESC FACC – Abbott Vascular ### 195226###Panel Discussant###CMO###Abbott Vascular###
Panel Discussant: Nick E. West, MA MD FRCP FESC FACC – Abbott Vascular
###
INFORMED CONSENT FOR SHOCK STUDIES WORKING GROUP

Navin K. Kapur, MD, FSCAI FAHA FACC – Tufts Medical Center ### 163156###Moderator###Executive Director, CVCRI###Tufts Medical Center###
Moderator: Navin K. Kapur, MD, FSCAI FAHA FACC – Tufts Medical Center
### @@@ John S. Sapirstein, MD – US Food and Drug Administration ### 627214###Moderator###Medical Officer###US Food and Drug Administration###
Moderator: John S. Sapirstein, MD – US Food and Drug Administration
###
Informed Consent for Shock Studies Working Group | Program Update

Nick E. West, MA MD FRCP FESC FACC – Abbott Vascular ### 195226###Speaker###CMO###Abbott Vascular###
Speaker: Nick E. West, MA MD FRCP FESC FACC – Abbott Vascular
###
Initial Experience from the LUX Valve - Why I’m Excited?

Thomas Modine, MD, PhD, MBA – CHU de Bordeaux ### 1803363###Speaker###Chief of structural and innovation ###CHU de Bordeaux ###
Speaker: Thomas Modine, MD, PhD, MBA – CHU de Bordeaux
###
Initiation of an ECPR Program-Lessons Learned

Anita R. Krueger, MD – Baylor Scott & White-All Saints Medical Center ### 851248###Speaker###Cardiothoracic Surgeon###Baylor Scott & White-All Saints Medical Center###
Speaker: Anita R. Krueger, MD – Baylor Scott & White-All Saints Medical Center
###
Innovation and New Technology

Shikhar Agarwal, MD MPH (he/him/his) – Geisinger Health System ### 1835459###Roundtable Participant###System Chief, Structural Heart Disease###Geisinger Health System###
Roundtable Participant: Shikhar Agarwal, MD MPH (he/him/his) – Geisinger Health System
### he/him/his @@@ Jorge Chavarria-Viquez, MD – Hospital Clinica Biblica ### 1835462###Roundtable Participant###Interventional Cardiologist###Hospital Clinica Biblica###
Roundtable Participant: Jorge Chavarria-Viquez, MD – Hospital Clinica Biblica
### @@@ Lindsey Cilia, MD (she/her/hers) – Inova Heart and Vascular Institute/Virginia Heart ### 1835464###Roundtable Participant###Co-Director of Complex Coronary Therapeutics Program Interventional Cardiologist ###Inova Heart and Vascular Institute/Virginia Heart###
Roundtable Participant: Lindsey Cilia, MD (she/her/hers) – Inova Heart and Vascular Institute/Virginia Heart
### she/her/hers @@@ Anahita Dua, MD MS MBA FACS – Harvard Medical School ### 488857###Roundtable Participant###Associate Professor of Surgery###Harvard Medical School###
Roundtable Participant: Anahita Dua, MD MS MBA FACS – Harvard Medical School
### @@@ Aakash Garg, MD – Ellis Hospital ### 1835436###Roundtable Participant###Director of Structural heart program###Ellis Hospital###
Roundtable Participant: Aakash Garg, MD – Ellis Hospital
### @@@ Tanush Gupta, MD (he/him/his) – The University of Vermont Medical Center ### 1835438###Roundtable Participant###Assistant Professor of Medicine###The University of Vermont Medical Center###
Roundtable Participant: Tanush Gupta, MD (he/him/his) – The University of Vermont Medical Center
### he/him/his @@@ Rim Halaby, MD – National Institutes of Health/National Heart, Lung, and Blood Institute ### 1835439###Roundtable Participant###Interventional Cardiologist/Staff Clinician###National Institutes of Health/National Heart, Lung, and Blood Institute###
Roundtable Participant: Rim Halaby, MD – National Institutes of Health/National Heart, Lung, and Blood Institute
### @@@ Ibrahim Inanc, MD – Kırıkkale Yuksek Ihtisas Hospital, Turkey ### 1545053###Roundtable Participant###Interventional Cardiologist###Kırıkkale Yuksek Ihtisas Hospital, Turkey###
Roundtable Participant: Ibrahim Inanc, MD – Kırıkkale Yuksek Ihtisas Hospital, Turkey
### @@@ Alejandro Lemor, MD, MS – University of Mississippi Medical Center ### 1835443###Roundtable Participant###Assistant Professor###University of Mississippi Medical Center###
Roundtable Participant: Alejandro Lemor, MD, MS – University of Mississippi Medical Center
### @@@ Anees Musallam, MD – Rambam Health Care Campus ### 675589###Roundtable Participant###Interventional cardiologist###Rambam Health Care Campus###
Roundtable Participant: Anees Musallam, MD – Rambam Health Care Campus
### @@@ Vinayak Nagaraja, MBBS MS MMed (Clin Epi) FRACP (he/him/his) – Mayo Clinic ### 1835445###Roundtable Participant###Interventional cardiologist###Mayo Clinic###
Roundtable Participant: Vinayak Nagaraja, MBBS MS MMed (Clin Epi) FRACP (he/him/his) – Mayo Clinic
### he/him/his @@@ Marco Pavani, MD – San Luigi Gonzaga University Hospital - Rivoli Hospital, Turin ### 1836908###Roundtable Participant###Interventional Cardiologist###San Luigi Gonzaga University Hospital - Rivoli Hospital, Turin###
Roundtable Participant: Marco Pavani, MD – San Luigi Gonzaga University Hospital - Rivoli Hospital, Turin
### @@@ Emily Perdoncin, MD – Kaiser Permanente San Francisco ### 1835448###Roundtable Participant###Interventional Cardiologist###Kaiser Permanente San Francisco###
Roundtable Participant: Emily Perdoncin, MD – Kaiser Permanente San Francisco
### @@@ Mona Ranade, MD – UCLA Health ### 1835452###Roundtable Participant###Assistant Professor###UCLA Health###
Roundtable Participant: Mona Ranade, MD – UCLA Health
### @@@ Zach Rosol, MD (he/him/his) – Baylor Heart and Vascular Institute/Baylor Scott White ### 1835453###Roundtable Participant###Interventional Cardiology###Baylor Heart and Vascular Institute/Baylor Scott White###
Roundtable Participant: Zach Rosol, MD (he/him/his) – Baylor Heart and Vascular Institute/Baylor Scott White
### he/him/his
INNOVATION FOR THE 2023 CATH LAB

Sam Chitsaz, MD FACC FSCAI – Sutter Health ### 1247735###Moderator###Interventional Cardiologist###Sutter Health###
Moderator: Sam Chitsaz, MD FACC FSCAI – Sutter Health
### @@@ Chaim Shaul Lotan, MD – Hadassah-Hebrew University Medical Center ### 235167###Moderator###Director Heart Institute###Hadassah-Hebrew University Medical Center###
Moderator: Chaim Shaul Lotan, MD – Hadassah-Hebrew University Medical Center
###
Innovation I: Question & Answer Discussion
Innovation II: Question & Answer Discussion
Innovation III: Question & Answer Discussion
Innovation IV: Question & Answer Discussion
Innovation IX: Question & Answer Discussion
Innovation V: Question & Answer Discussion
Innovation VI: Question & Answer Discussion
Innovation VII: Question & Answer Discussion
Innovation VIII Question & Answer Discussion
Innovation X: Question & Answer Discussion
Innovations HUB: CRT's Best Innovation Competition (Non-CME)

Steven R. Bailey, MD, MSCAI – LSU Health Shreveport ### 163014###Program Director###Professor and Chairman, Department of Medicine LSU Health Shreveport###LSU Health Shreveport###
Program Director: Steven R. Bailey, MD, MSCAI – LSU Health Shreveport
### @@@ Rich R. Heuser, MD, MSCAI – Heart and Vascular Center of Arizona ### 163137###Program Director###Interventional Cardiologist###Heart and Vascular Center of Arizona###
Program Director: Rich R. Heuser, MD, MSCAI – Heart and Vascular Center of Arizona
### @@@ Toby Rogers, MD, PhD – Georgetown University and MedStar Washington Hospital Center ### 185869###Program Director###Associate Professor of Medicine (Cardiology) and Scientific Lead for Structural Heart Disease###Georgetown University and MedStar Washington Hospital Center###
Program Director: Toby Rogers, MD, PhD – Georgetown University and MedStar Washington Hospital Center
###
Innovations Hub: General (Non-CME)

Steven R. Bailey, MD, MSCAI – LSU Health Shreveport ### 163014###Program Director###Professor and Chairman, Department of Medicine LSU Health Shreveport###LSU Health Shreveport###
Program Director: Steven R. Bailey, MD, MSCAI – LSU Health Shreveport
### @@@ Rich R. Heuser, MD, MSCAI – Heart and Vascular Center of Arizona ### 163137###Program Director###Interventional Cardiologist###Heart and Vascular Center of Arizona###
Program Director: Rich R. Heuser, MD, MSCAI – Heart and Vascular Center of Arizona
### @@@ Toby Rogers, MD, PhD – Georgetown University and MedStar Washington Hospital Center ### 185869###Program Director###Associate Professor of Medicine (Cardiology) and Scientific Lead for Structural Heart Disease###Georgetown University and MedStar Washington Hospital Center###
Program Director: Toby Rogers, MD, PhD – Georgetown University and MedStar Washington Hospital Center
###
Innovations Hub: Heart Failure (Non-CME)

William T. Abraham, MD – The Ohio State University ### 627210###Program Director###Professor of Medicine###The Ohio State University###
Program Director: William T. Abraham, MD – The Ohio State University
### @@@ Farooq Sheikh, MD – MedStar Health, Georgetown University School of Medicine ### 1526121###Program Director###Medical Director, Advanced Heart Failure Program###MedStar Health, Georgetown University School of Medicine###
Program Director: Farooq Sheikh, MD – MedStar Health, Georgetown University School of Medicine
###
INNOVATIONS IN 2023

Steven R. Bailey, MD, MSCAI – LSU Health Shreveport ### 163014###Moderator###Professor and Chairman, Department of Medicine LSU Health Shreveport###LSU Health Shreveport###
Moderator: Steven R. Bailey, MD, MSCAI – LSU Health Shreveport
### @@@ Robert S. Schwartz, MD, FACC, FSCAI – DeHaan Center for Medical Innovation ### 163287###Moderator###President###DeHaan Center for Medical Innovation###
Moderator: Robert S. Schwartz, MD, FACC, FSCAI – DeHaan Center for Medical Innovation
###
Innovations in Cardiovascular Interventions: From Idea to the Bedside

Chaim Shaul Lotan, MD – Hadassah-Hebrew University Medical Center ### 235167###Speaker###Director Heart Institute###Hadassah-Hebrew University Medical Center###
Speaker: Chaim Shaul Lotan, MD – Hadassah-Hebrew University Medical Center
###
INSIGHTS INTO THE PATHOPHYSIOLOGY AND MECHANISMS AND IMAGING OF THE ATHEROSCLEROTIC DISEASE

Habib Samady, MD, FACC, FSCAI – Georgia Heart Institute, Northeast Georgia Medical Center ### 163279###Moderator###President, Georgia Heart Institute###Georgia Heart Institute, Northeast Georgia Medical Center###
Moderator: Habib Samady, MD, FACC, FSCAI – Georgia Heart Institute, Northeast Georgia Medical Center
### @@@ Angela M. Taylor, MD, MS – University of Virginia ### 555069###Moderator###Professor ###University of Virginia###
Moderator: Angela M. Taylor, MD, MS – University of Virginia
### @@@ Renu Virmani, MD – CVPath Institute, Inc. ### 163332###Moderator###President###CVPath Institute, Inc.###
Moderator: Renu Virmani, MD – CVPath Institute, Inc.
###
Instantaneous Wave-Free Ratio Measurement Complicated by Ventricular Flutter

Tudor Sturzoiu, MD ### 1871965###Speaker#########
Speaker: Tudor Sturzoiu, MD
###
In-Stent Restenosis: OCT Based Causes and Therapies

Hayder D. Hashim, MD – Medstar Washington Hospital Center/Georgetown University ### 672368###Speaker###Interventional Cardiologist###Medstar Washington Hospital Center/Georgetown University ###
Speaker: Hayder D. Hashim, MD – Medstar Washington Hospital Center/Georgetown University
###
Integrating FFRangio into Today's Cath Lab: A Case Based Discussion

Akiko Maehara, MD – Columbia University Medical Center ### 163201###Speaker###Professor###Columbia University Medical Center###
Speaker: Akiko Maehara, MD – Columbia University Medical Center
###
INTER ATRIAL SHUNTS

William T. Abraham, MD – The Ohio State University ### 627210###Moderator###Professor of Medicine###The Ohio State University###
Moderator: William T. Abraham, MD – The Ohio State University
### @@@ Megan Coylewright, MD, MPH – The Erlanger Heart and Lung Institute ### 194917###Moderator###Vice Chief of Cardiology and Director of Structural Heart Program###The Erlanger Heart and Lung Institute###
Moderator: Megan Coylewright, MD, MPH – The Erlanger Heart and Lung Institute
###
Inter Atrial Shunts: Nothing Left Behind: The Noya Approach to a Trial Site

Chaim Shaul Lotan, MD – Hadassah-Hebrew University Medical Center ### 235167###Speaker###Director Heart Institute###Hadassah-Hebrew University Medical Center###
Speaker: Chaim Shaul Lotan, MD – Hadassah-Hebrew University Medical Center
###
Interaction between the MitraClip and the Mitral Valve Apparatus: Anatomic Insights from a Cadaver Human Heart

Issam Moussa, MD – Carle Illinois College of Medicine / University of Illinois Urbana Champaign ### 388128###Speaker###Associate Dean for Research and Innovation###Carle Illinois College of Medicine / University of Illinois Urbana Champaign###
Speaker: Issam Moussa, MD – Carle Illinois College of Medicine / University of Illinois Urbana Champaign
###
Interesting Case Discussions as a Workhorse Valve

Ron Waksman, MD, MSCAI – MedStar Washington Hospital Center, MedStar Heart and Vascular Institute ### 161917###Panel Moderator###Director, Cardiovascular Research and Advanced Education###MedStar Washington Hospital Center, MedStar Heart and Vascular Institute###
Panel Moderator: Ron Waksman, MD, MSCAI – MedStar Washington Hospital Center, MedStar Heart and Vascular Institute
### @@@ Gregory P. Fontana, MD (he/him/his) – Hospital Corporation of America ### 906436###Panel Discussant###Director, CardioVascular Institute###Hospital Corporation of America###
Panel Discussant: Gregory P. Fontana, MD (he/him/his) – Hospital Corporation of America
### he/him/his @@@ Paul D. Mahoney, MD, FACC – Sentara Health ### 478297###Panel Discussant###Director, Structural Heart Program###Sentara Health###
Panel Discussant: Paul D. Mahoney, MD, FACC – Sentara Health
### @@@ Michael J. Reardon, MD – Houston Methodist DeBakey Heart & Vascular Center ### 163255###Panel Discussant###Professor and Allison Family Distinguished Chair of Cardiovascular Research###Houston Methodist DeBakey Heart & Vascular Center###
Panel Discussant: Michael J. Reardon, MD – Houston Methodist DeBakey Heart & Vascular Center
### @@@ Paul D. Mahoney, MD, FACC – Sentara Health ### 478297###Speaker###Director, Structural Heart Program###Sentara Health###
Speaker: Paul D. Mahoney, MD, FACC – Sentara Health
###
Intraprocedural Coronary Sinus Reducer Embolisation to the Right Pulmonary Artery

Rachel H. Pathimagaraj, BSc – Imperial College London ### 1872245###Speaker###Final Year Medical Student ###Imperial College London ###
Speaker: Rachel H. Pathimagaraj, BSc – Imperial College London
###
Intravascular Imaging Artifacts: IVUS and OCT

Francesco Prati, MD – San Giovanni Hospital Rome, Italy ### 1418654###Speaker###Chief Cardiovascular Department###San Giovanni Hospital Rome, Italy###
Speaker: Francesco Prati, MD – San Giovanni Hospital Rome, Italy
###
INTRAVASCULAR IMAGING SOLVE MY CASE: MOST CHALLENGING CASES BY EXPERTS

Giulio Guagliumi, Sr., MD (he/him/his) – IRCCS Galeazzi Sant'Ambrogio Hospital, ### 867645###Moderator### Interventional Cardiology###IRCCS Galeazzi Sant'Ambrogio Hospital, ###
Moderator: Giulio Guagliumi, Sr., MD (he/him/his) – IRCCS Galeazzi Sant'Ambrogio Hospital,
### he/him/his @@@ Megha Prasad, MD – Columbia university ### 1432184###Moderator###Assistant professor ###Columbia university ###
Moderator: Megha Prasad, MD – Columbia university
### @@@ Evan Shlofmitz, DO – St. Francis Hospital - The Heart Center ### 318231###Moderator###Director of Intravascular Imaging###St. Francis Hospital - The Heart Center###
Moderator: Evan Shlofmitz, DO – St. Francis Hospital - The Heart Center
###
Intravascular Lithotripsy For Treatment Of Severely Calcified Coronary Artery Disease In A Real-life Setting: Results From The Replica-Epic18 Study

Belen Cid Alvarez, MD, PhD (she/her/hers) – Hospital Clínico Universitario Santiago de Compostela ### 1871467###Speaker###Dr###Hospital Clínico Universitario Santiago de Compostela###
Speaker: Belen Cid Alvarez, MD, PhD (she/her/hers) – Hospital Clínico Universitario Santiago de Compostela
### she/her/hers
INTREPID: The Transfemoral Option

Firas Zahr, MD – OHSU ### 1520151###Speaker###Director, Interventional Cardiology###OHSU###
Speaker: Firas Zahr, MD – OHSU
###
Intro Understanding Appropriate Impella® Usage in HRPCI

William W. O'Neill, MD, FACC, MSCAI – Henry Ford Health Systems ### 184723###Speaker###Medical Director###Henry Ford Health Systems###
Speaker: William W. O'Neill, MD, FACC, MSCAI – Henry Ford Health Systems
###
Introduction

Suzanne J. Baron, MD, MSc – Lahey Hospital and Medical Center ### 195293###Speaker###Interventional Cardiologist###Lahey Hospital and Medical Center###
Speaker: Suzanne J. Baron, MD, MSc – Lahey Hospital and Medical Center
###
Introduction and Overview of CMD

Hayder D. Hashim, MD – Medstar Washington Hospital Center/Georgetown University ### 672368###Speaker###Interventional Cardiologist###Medstar Washington Hospital Center/Georgetown University ###
Speaker: Hayder D. Hashim, MD – Medstar Washington Hospital Center/Georgetown University
###
Introduction and Session Objectives

Alexandre A. Abizaid, MD, PhD – Incor ### 162997###Speaker###Director of Invasive Cardiology###Incor###
Speaker: Alexandre A. Abizaid, MD, PhD – Incor
###
INTRODUCTION TO CTO

Carlo Di Mario, MD – University of Florence ### 163084###Moderator###Professor###University of Florence###
Moderator: Carlo Di Mario, MD – University of Florence
### @@@ Robert Gallino, MD – Cardiology Associates, LLC ### 163107###Moderator###Co Director of CTO program at MWHC ###Cardiology Associates, LLC###
Moderator: Robert Gallino, MD – Cardiology Associates, LLC
### @@@ Jaikirshan Khatri, MD – Cleveland Clinic ### 1214772###Moderator###Director of Complex Coronary Intervention###Cleveland Clinic###
Moderator: Jaikirshan Khatri, MD – Cleveland Clinic
### @@@ Stephane Rinfret, MD, SM (he/him/his) – Emory Heart and Vascular ### 1825077###Moderator###Associate Director of Complex Coronary Interventions###Emory Heart and Vascular###
Moderator: Stephane Rinfret, MD, SM (he/him/his) – Emory Heart and Vascular
### he/him/his
Introduction to Harmonization by Doing: What Have we Accomplished?

Mitchell Krucoff, MD, FACC (he/him/his) – Duke University Medical Center/Duke Clinical Research Institute ### 163174###Speaker###Professor Medicine/Cardiology###Duke University Medical Center/Duke Clinical Research Institute###
Speaker: Mitchell Krucoff, MD, FACC (he/him/his) – Duke University Medical Center/Duke Clinical Research Institute
### he/him/his
Introduction to Navitor and Clinical Data Review

Michael J. Reardon, MD – Houston Methodist DeBakey Heart & Vascular Center ### 163255###Speaker###Professor and Allison Family Distinguished Chair of Cardiovascular Research###Houston Methodist DeBakey Heart & Vascular Center###
Speaker: Michael J. Reardon, MD – Houston Methodist DeBakey Heart & Vascular Center
###
Investigation of the Effects of Dietary Nitrate on Vascular Function, Platelet Reactivity and Restenosis in Patients with Stable Angina (NITRATE-OCT Study)

Krishnaraj S. Rathod, MBBS, BMedSci (Hons), MRCP (UK), PhD, QDip – Bart Heart Centre, St. Bartholomew's Hospital ### 670607###Speaker###Interventional Cardiologist###Bart Heart Centre, St. Bartholomew's Hospital###
Speaker: Krishnaraj S. Rathod, MBBS, BMedSci (Hons), MRCP (UK), PhD, QDip – Bart Heart Centre, St. Bartholomew's Hospital
###
Is Antiplatelet Therapy Sufficient for DRT and Stroke Prevention After LAAC?
Is DK Crush Stenting is a Crushing Blow to Other Rival Techniques in LM Bifurcation?

Dr Debabrata Dash, MD, DM, FICC, FSCAI, FAPSC, FCCP, FACC, FESC – Aster Hospital, Al Mankhool Dubai, UAE ### 828357###Speaker###Consultant Interventional Cardiologist###Aster Hospital, Al Mankhool Dubai, UAE###
Speaker: Dr Debabrata Dash, MD, DM, FICC, FSCAI, FAPSC, FCCP, FACC, FESC – Aster Hospital, Al Mankhool Dubai, UAE
###
Is Imaging Mandatory for Left Main PCI?

Darshan Doshi, MD, MS – Massachusetts General Hospital / Harvard Medical School ### 926239###Speaker###Interventional Cardiologist###Massachusetts General Hospital / Harvard Medical School###
Speaker: Darshan Doshi, MD, MS – Massachusetts General Hospital / Harvard Medical School
###
Is it Time to Reconsider CABG in Acute MI? If So, What is Required?

Moritz C. Wyler von Ballmoos, MD, PhD, MPH – University Hospital Zurich ### 671078###Speaker###Associate Professor###University Hospital Zurich###
Speaker: Moritz C. Wyler von Ballmoos, MD, PhD, MPH – University Hospital Zurich
###
Is it Time to Treat Vulnerable Plaque? Insights from Pharmacology and Interventional Trials

Gregg W. Stone, MD, FACC, MSCAI – Mount Sinai ### 163300###Speaker###Physician###Mount Sinai###
Speaker: Gregg W. Stone, MD, FACC, MSCAI – Mount Sinai
###
Is Targeting Platelets and Coagulation Sufficient to Reduce the Risk of Ischemic Event Associated with Vulnerable Plaque Rupture

Paul A. Gurbel, MD, FSCAI – Sinai Center for Thrombosis Research and Drug Development ### 163126###Speaker###Director###Sinai Center for Thrombosis Research and Drug Development###
Speaker: Paul A. Gurbel, MD, FSCAI – Sinai Center for Thrombosis Research and Drug Development
###
Is Targeting Platelets and Coagulation Sufficient to Reduce the Risk of Ischemic Event Associated with Vulnerable Plaque Rupture

Paul A. Gurbel, MD, FSCAI – Sinai Center for Thrombosis Research and Drug Development ### 163126###Speaker###Director###Sinai Center for Thrombosis Research and Drug Development###
Speaker: Paul A. Gurbel, MD, FSCAI – Sinai Center for Thrombosis Research and Drug Development
###
Is the Pulmonary Artery Catheter Necessary to Manage Cardiogenic Shock?

Mohit Pahuja, MD – University of Oklahoma Medical Center ### 1519862###Speaker###Assistant Professor of Medicine, Division of Interventional and advanced heart failure cardiology###University of Oklahoma Medical Center###
Speaker: Mohit Pahuja, MD – University of Oklahoma Medical Center
###
Is There an Unmet Need for Device Treatment for Moderate Hypertension?

Judith Veis, MD – Medstar Washington Hospital Center ### 188316###Speaker###Section Director, Nephrology###Medstar Washington Hospital Center###
Speaker: Judith Veis, MD – Medstar Washington Hospital Center
###
Ischemia with and Without Visible CAD – What’s Going On?

Rasha Al-Lamee, MA, MD, PhD – Imperial College London ### 195289###Speaker###Interventional Cardiology Consultant###Imperial College London###
Speaker: Rasha Al-Lamee, MA, MD, PhD – Imperial College London
###
Ischemia with no Obstructive Coronary Arteries: Beyond the Coronary Angiogram

Janet Wei, MD (she/her/hers) – Cedars-Sinai Smidt Heart Institute ### 1213181###Speaker###Associate Program Director, Cardiology Fellowship Training Program###Cedars-Sinai Smidt Heart Institute###
Speaker: Janet Wei, MD (she/her/hers) – Cedars-Sinai Smidt Heart Institute
### she/her/hers
“It’s Never Happened to me Before” How to Troubleshoot an Entrapped Rotablator Burr Without Panicking

Kavin A. Arasar, MD (she/her/hers) – University of Illinois at Chicago ### 1871959###Speaker###Fellow###University of Illinois at Chicago###
Speaker: Kavin A. Arasar, MD (she/her/hers) – University of Illinois at Chicago
### she/her/hers
IVL for Lesion Modification: When do I Use It?

Eric J. Dippel, MD – Vascular Institute of the Midwest, PC ### 163085###Speaker###Interventional Cardiologist###Vascular Institute of the Midwest, PC###
Speaker: Eric J. Dippel, MD – Vascular Institute of the Midwest, PC
###
IVUS 1,2,3: Guiding Modern PCI

Kathleen E. Kearney, MD – University of Washington ### 932524###Speaker###Assistant Professor###University of Washington###
Speaker: Kathleen E. Kearney, MD – University of Washington
###
IVUS CHIP

Robert Diletti, MD ### 467902###Speaker#########
Speaker: Robert Diletti, MD
### @@@ Nicolas M. Van Mieghem, MD, PhD, FESC, FACC – Thoraxcenter ### 263756###Speaker###Professor and Clinical Director of Interventional cardiology###Thoraxcenter###
Speaker: Nicolas M. Van Mieghem, MD, PhD, FESC, FACC – Thoraxcenter
###
IVUS Guidance in CTO PCI

Jaikirshan Khatri, MD – Cleveland Clinic ### 1214772###Speaker###Director of Complex Coronary Intervention###Cleveland Clinic###
Speaker: Jaikirshan Khatri, MD – Cleveland Clinic
###